Inventiva Sa (IVA) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Inventiva Sa

NASDAQ | IVA

3.03

USD

-0.07 (-2.26%)

AT CLOSE (AS OF Apr 3, 2025)

$230M

MARKET CAP

P/E Ratio

-2.14

EPS

52 Week High

$1.5

52 Week Low

LIFE SCIENCES

Sector

IVA Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

IVA Technicals

Tags:

IVA Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field	Value (EUR)
Gross Profit	$18M
Total Revenue	$17M
Cost Of Revenue	-$23K
Costof Goods And Services Sold	-$23K
Operating Income	-$103M
Selling General And Administrative	$14M
Research And Development	$110M
Operating Expenses	$120M
Investment Income Net	-
Net Interest Income	-$4.2M
Interest Income	$991K
Interest Expense	$5.2M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$2.6M
Income Before Tax	-$110M
Income Tax Expense	$607K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$110M
Comprehensive Income Net Of Tax	-
Ebit	-$105M
Ebitda	-$102M
Net Income	-$110M

Revenue & Profitability

Earnings Performance

IVA Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2023)

Field	Value (USD)
Total Assets	$70M
Total Current Assets	$48M
Cash And Cash Equivalents At Carrying Value	$27M
Cash And Short Term Investments	$27M
Inventory	$417K
Current Net Receivables	-
Total Non Current Assets	$21M
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$541K
Intangible Assets Excluding Goodwill	$541K
Goodwill	-
Investments	-
Long Term Investments	$10M
Short Term Investments	$70K
Other Current Assets	$17M
Other Non Current Assets	-
Total Liabilities	$102M
Total Current Liabilities	$50M
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$5.3M
Total Non Current Liabilities	$51M
Capital Lease Obligations	$6.6M
Long Term Debt	$28M
Current Long Term Debt	$3M
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$37M
Other Current Liabilities	$3.6M
Other Non Current Liabilities	$6.3M
Total Shareholder Equity	-$32M
Treasury Stock	-
Retained Earnings	-$110M
Common Stock	$521K
Common Stock Shares Outstanding	$45M

yearly Cash Flow (As of Dec 31, 2023)

Field	Value (EUR)
Operating Cashflow	-$82M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$2.6M
Capital Expenditures	$540K
Change In Receivables	-
Change In Inventory	-$44K
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	$29M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$110M

yearly Income Statement (As of Dec 31, 2023)

Field	Value (EUR)
Gross Profit	$18M
Total Revenue	$17M
Cost Of Revenue	-$23K
Costof Goods And Services Sold	-$23K
Operating Income	-$103M
Selling General And Administrative	$14M
Research And Development	$110M
Operating Expenses	$120M
Investment Income Net	-
Net Interest Income	-$4.2M
Interest Income	$991K
Interest Expense	$5.2M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$2.6M
Income Before Tax	-$110M
Income Tax Expense	$607K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$110M
Comprehensive Income Net Of Tax	-
Ebit	-$105M
Ebitda	-$102M
Net Income	-$110M

IVA Profile

Inventiva Sa Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidosis (MPS) and other diseases. The company is headquartered in Daix, France.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	13.04%	-	706,860,781
NVDA	$103.14	-6.59%	$2.68T	263,349,217
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	210,875,217
PTIX	$0.43	91.50%	$4.04M	173,208,693

Symbol	Price	Change %	Market Cap	Volume
JNJ	$160.56	3.35%	$399.65B	9,908,361
PG	$172.57	1.81%	$399.61B	6,993,394
NVO	$67.12	-1.65%	$308.32B	8,797,694
AZN	$74.03	2.50%	$225.70B	6,150,517
MRK	$86.38	-0.25%	$220.07B	12,113,104

Symbol	Price	Change %	Market Cap	Volume
VCIG	$6.06	1,818.33%	$26.40M	302,396
MKTW	$9.19	1,684.81%	$19.91M	117,875
ICCT	$4.38	111.59%	$9.78M	168,784,937
PTIX	$0.43	91.50%	$4.04M	173,208,693
MRM	$0.65	74.84%	$2.91M	51,693,935

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,865,554
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669

Quick Links

IVA $3.03 (-2.26%) Quote details